← All Authorities
United States Leading Case patents

Amgen Inc v Sanofi (Patent Enablement)

598 U.S. 594 (2023)
JurisdictionUnited States
CourtUS Supreme Court
Year2023
StatusBinding authority

Summary

A patent must enable the full scope of its claims; functional genus claims require enablement commensurate with the breadth of the claimed invention.

Key Principle

A patent must enable the full scope of the invention; claiming by function at the genus level requires broad enablement.

Area of Law

ip

Related Cases

Cantarella Bros Pty Ltd v Modena Trading Pty Ltd (2014) 254 CLR 337

Foreign words used as trademarks are assessed for descriptiveness in the Australian English-speaking market; Italian words for coffee were registrable as not inherently descriptive.

Phonographic Performance Company of Australia Ltd v Commonwealth (2012) 246 CLR 561

Statutory licence scheme for sound recordings validly enacted under constitutional copyright power and did not constitute an unjust acquisition of property.

Roadshow Films Pty Ltd v iiNet Ltd (2012) 248 CLR 42

An ISP that failed to act on infringement notices did not authorise subscribers' copyright infringement via BitTorrent, as it lacked the requisite control over the infringing acts.

Ask CommonBench about this case

Get a detailed analysis of Amgen Inc v Sanofi (Patent Enablement) and how it applies to your situation.

Explain Amgen Inc v Sanofi (Patent Ena...